Stay updated on MRTX849 in KRAS G12C Cancer: Clinical Trial

Sign up to get notified when there's something new on the MRTX849 in KRAS G12C Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRTX849 in KRAS G12C Cancer: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:17:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details and navigation. This indicates the study record cannot be accessed at this time.
    Difference
    17%
    Check dated 2026-09-22T21:54:10.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page's revision label has been updated to v3.7.0, replacing the previous v3.6.6 revision tag.
    Difference
    0.0%
    Check dated 2026-09-15T21:49:07.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a backend page update that refreshes the page without altering core study details.
    Difference
    0.0%
    Check dated 2026-09-01T19:51:42.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, indicating a newer version of the study page.
    Difference
    0.0%
    Check dated 2026-08-11T22:47:33.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    New IPD data sharing information was added, including Plan Description, Access Criteria, Time Frame, and Supporting Information Type, plus the IPD Sharing URL. The update also includes text about BMS providing access to anonymized IPD for qualified researchers and references to related documents such as the CSR, SAP, and Study Protocol.
    Difference
    0.3%
    Check dated 2026-08-04T23:43:48.000Z thumbnail image

Stay in the know with updates to MRTX849 in KRAS G12C Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRTX849 in KRAS G12C Cancer: Clinical Trial page.